John W. Zinckgraf, Ph.D.
Affiliations: | 2001 | University of Connecticut, Storrs, CT, United States |
Area:
Immunology, Molecular BiologyGoogle:
"John Zinckgraf"Parents
Sign in to add mentor| Lawrence K. Silbart | grad student | 2001 | University of Connecticut | |
| (Modulating immune responses with DNA vaccine constructs expressing differing levels of antigen.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wanczyk H, Barker T, Rood D, et al. (2013) Cloning and characterization of a hybridoma secreting a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-specific monoclonal antibody and recombinant F(ab). Toxins. 5: 568-89 |
| Zinckgraf JW, Sposato M, Zielinski V, et al. (2009) Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. Vaccine. 27: 5393-401 |
| Xu M, Lu X, Sposato M, et al. (2009) Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers. Vaccine. 27: 4641-7 |
| Challa S, Barrette R, Rood D, et al. (2007) Non-toxic Pseudomonas aeruginosa exotoxin A expressing the FMDV VP1 G-H loop for mucosal vaccination of swine against foot and mouth disease virus. Vaccine. 25: 3328-37 |
| Tangri S, Mothé BR, Eisenbraun J, et al. (2005) Rationally engineered therapeutic proteins with reduced immunogenicity. Journal of Immunology (Baltimore, Md. : 1950). 174: 3187-96 |
| Zinckgraf JW, Silbart LK. (2003) Modulating gene expression using DNA vaccines with different 3'-UTRs influences antibody titer, seroconversion and cytokine profiles. Vaccine. 21: 1640-9 |
| Zinckgraf JW, Winchell JM, Silbart LK. (1999) Antibody responses to a mucosally delivered HIV-1 gp120-derived C4/V3 peptide. Journal of Reproductive Immunology. 45: 99-112 |